Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
about
Antiplatelet resistance in strokePlatelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patientsFish oil metabolites: translating promising findings from bench to bedside to reduce cardiovascular diseaseHemostatic function to regulate perioperative bleeding in patients undergoing spinal surgery: A prospective observational studyPharmacometabolomics reveals that serotonin is implicated in aspirin response variabilityPlatelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease.The evaluation method for antiplatelet effect of acetylsalicylic acid.Native platelet aggregation and response to aspirin in persons with the metabolic syndrome and its componentsIdentification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression.Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans.Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics StudyPharmacogenomics of platelet responsiveness to aspirin.Increases in ambient particulate matter air pollution, acute changes in platelet function, and effect modification by aspirin and omega-3 fatty acids: A panel studyAspirin resistance: biological and clinical implications.Combination antiplatelet agents for secondary prevention of ischemic stroke.Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease.Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation.Cangrelor: a novel P2Y12 receptor antagonist.The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Influence of nonsteroidal anti-inflammatory drugs on aspirin's antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction.Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.Functional testing methods for the antiplatelet effects of aspirin.A contemporary viewpoint on 'aspirin resistance'.Monitoring aspirin and clopidogrel response: testing controversies and recommendations.Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?Antiplatelet Resistance-Does it Exist and How to Measure it?Aspirin can stimulate luminol-enhanced chemiluminescence of activated platelets.Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals.Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery.Obesity and Altered Aspirin Pharmacology.Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel.Antioxidant and antiplatelet activities of flavonoid-rich fractions of three citrus fruits from Korea.
P2860
Q22305927-8902BCAD-DAEF-4A9A-B208-E1A260017ABFQ28220600-B6B71DA1-DCC1-4B26-923A-1DDCB5CF85C3Q28385429-CD5D9C2B-12BC-46C2-A0E5-98A29C514CB5Q33807064-BEF392BE-DF7B-4EDB-B97A-B661E8292A03Q33994559-CB407075-C918-4A8C-ACBD-699BE82A7DE1Q34572277-E6C278B1-5622-4664-A99B-1BED78F94FDBQ35074234-6F9D4ED6-B798-48A5-A00B-0C096C728890Q35104024-A1A28940-7AB3-4054-8E6E-984028C1A779Q35230231-9E689F42-7D89-4929-9948-A3DAB2833112Q35916268-035D5B04-AC23-4E3D-A939-0C31E03A6C55Q36659192-7C0D939A-5445-44B2-B6A6-4651601AC555Q36802113-FA35577E-8050-46C7-800B-CC368D0BF10CQ36835930-86BD35E9-18CD-4277-AFD9-09443CE778F5Q36989841-01800183-61D5-4BBB-A70C-19CDA78C55B5Q37033456-863EE118-16F6-436C-BC7C-408FDE7A9A61Q37089560-6CD7732E-0E7A-4CDF-A57F-CC99B416A313Q37281572-163377E0-4A5D-4B05-BA02-18FDF0919751Q37389964-791B2723-AFE7-494D-95AC-831863B22849Q37407281-D969358F-E464-4BE9-9DFB-315F607E9E75Q37551923-8F9E8BCA-7FD0-484E-95C2-5E65E5C25028Q37612293-1F438218-F5F1-484B-A194-34F6F0141533Q37629641-94D4A885-804F-4C6B-A425-3F6CE49DED80Q37692578-460D46A5-24AA-4CB6-BBFC-5EF07E6BE80EQ37726989-F7F88129-7251-4B85-B57B-9BEDB4943402Q37841562-75D4D271-2700-4075-B640-B9215C9F89BFQ37989558-870F8972-D809-4EDD-8458-3E2BDC1FC046Q38099235-44441C19-6F72-4DC6-A885-E5B0F44EFF18Q39025194-A5B61B90-9DF3-470E-A558-7097A2933125Q40014803-144E9D9D-4825-49D7-BD7D-0566F687A13FQ43072125-CC424148-4511-4D30-A7A8-5EDD4005F8C0Q45180360-A3131DC9-E94C-4F19-B2BB-26B937D235F2Q46087815-D1FAF45A-A2B2-49AA-BF0E-1A54C22FEA55Q48302820-C3D432BF-7982-4DC0-A6A5-BAD68060A500Q52641652-8EAB617C-F38D-4BBA-9656-35E0042EE741Q55117060-6CDA3CAE-8251-440A-B942-F448BF1D831B
P2860
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@ast
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@en
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@nl
type
label
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@ast
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@en
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@nl
prefLabel
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@ast
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@en
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@nl
P2093
P2860
P921
P3181
P1476
Aspirin resistance detected wi ...... ts of aspirin-treated patients
@en
P2093
Y Kobayashi
P2860
P304
P3181
P356
10.1111/J.1538-7836.2006.01958.X
P407
P577
2006-06-01T00:00:00Z